What is it about?
extraction, identification, and biological evaluation of active metabolites isolated from SUK 25 against three MRSA strains, namely, MRSA ATCC 43300, MRSA ATCC 33591, and MRSA ATCC 49476.
Featured Image
Why is it important?
SUK 25 isolated from Z. spectabile can be regarded as a new valuable source to produce secondary metabolites against bacteria, especially MRSA.
Perspectives
Muhanna Mohammed Alshaibani. PhD student in Programme of Biomedical Science, School of Diagnostic and Applied Health Sciences, Faculty of Health Sciences.
Dr Muhanna Alshaibani
1Programme of Biomedical Science, School of Diagnostic and Applied Health Sciences, Faculty of Health Sciences. UKM
Read the Original
This page is a summary of: Isolation and characterization of cyclo-(tryptophanyl-prolyl) and chloramphenicol from Streptomyces sp. SUK 25 with antimethicillin-resistant Staphylococcus aureus activity, Drug Design Development and Therapy, May 2016, Dove Medical Press,
DOI: 10.2147/dddt.s101212.
You can read the full text:
Contributors
The following have contributed to this page
